カテゴリー： 世界, 医療/バイオ, QYResearch

吸入器＆ネブライザーのグローバル市場2023年：吸入器、ネブライザー

【英語タイトル】Global Inhalers and Nebulizers Market Research Report 2023

QYResearchが出版した調査資料（QYR23MA7988）・商品コード：QYR23MA7988
・発行会社（調査会社）：QYResearch
・発行日：2023年3月（※2025年版があります。お問い合わせください。）
・ページ数：106
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル
・産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥417,600見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥626,400見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥835,200見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

本調査レポートは世界の吸入器＆ネブライザー市場について調査・分析し、世界の吸入器＆ネブライザー市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（吸入器、ネブライザー）、用途別セグメント分析（喘息、COPD、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、GSK、AstraZeneca、Chiesi、Boehringer Ingelheim、Novartis、Teva、Organon、PARI GmbH、Omron、Philips、Drive DeVilbiss Healthcare、Yuwell、Leyi、Folee、Beurerなどが含まれています。世界の吸入器＆ネブライザー市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、吸入器＆ネブライザー市場規模を推定する際に考慮しました。

・吸入器＆ネブライザー市場の概要
- 製品の定義
- 吸入器＆ネブライザーのタイプ別セグメント
- 世界の吸入器＆ネブライザー市場規模：タイプ別分析（吸入器、ネブライザー）
- 吸入器＆ネブライザーの用途別セグメント
- 世界の吸入器＆ネブライザー市場規模：用途別分析（喘息、COPD、その他）
- 世界の吸入器＆ネブライザー市場規模予測（2018年-2029年）
- 吸入器＆ネブライザーの平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- 吸入器＆ネブライザー市場の競争状況およびトレンド

・吸入器＆ネブライザーの地域別市場規模
- 北米の吸入器＆ネブライザー市場規模（2018年-2029年）
- アメリカの吸入器＆ネブライザー市場規模（2018年-2029年）
- ヨーロッパの吸入器＆ネブライザー市場規模（2018年-2029年）
- アジア太平洋の吸入器＆ネブライザー市場規模（2018年-2029年）
- 中国の吸入器＆ネブライザー市場規模（2018年-2029年）
- 日本の吸入器＆ネブライザー市場規模（2018年-2029年）
- 韓国の吸入器＆ネブライザー市場規模（2018年-2029年）
- インドの吸入器＆ネブライザー市場規模（2018年-2029年）
- オーストラリアの吸入器＆ネブライザー市場規模（2018年-2029年）
- 中南米の吸入器＆ネブライザー市場規模（2018年-2029年）
- 中東・アフリカの吸入器＆ネブライザー市場規模（2018年-2029年）

・タイプ別セグメント：吸入器、ネブライザー
- 世界の吸入器＆ネブライザーのタイプ別販売量（2018年-2023年）
- 世界の吸入器＆ネブライザーのタイプ別売上（2018年-2023年）
- 世界の吸入器＆ネブライザーのタイプ別価格

・用途別セグメント：喘息、COPD、その他
- 世界の吸入器＆ネブライザーの用途別販売量（2018年-2023年）
- 世界の吸入器＆ネブライザーの用途別売上（2018年-2023年）
- 世界の吸入器＆ネブライザーの用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
GSK、AstraZeneca、Chiesi、Boehringer Ingelheim、Novartis、Teva、Organon、PARI GmbH、Omron、Philips、Drive DeVilbiss Healthcare、Yuwell、Leyi、Folee、Beurer

・産業チェーンと販売チャネルの分析
- 吸入器＆ネブライザー産業チェーン分析
- 吸入器＆ネブライザーの主要原材料
- 吸入器＆ネブライザーの販売チャネル
- 吸入器＆ネブライザーのディストリビューター
- 吸入器＆ネブライザーの主要顧客

・吸入器＆ネブライザー市場ダイナミクス
- 吸入器＆ネブライザーの業界動向
- 吸入器＆ネブライザー市場の成長ドライバ、課題、阻害要因

・調査成果および結論

・調査方法とデータソース

Inhalers and nebulizers are two different devices used to deliver quick-relief medicines (also called rescue or fast-acting medicines) or long-term control medicines (also called controller or maintenance medicines) directly into the lungs
Highlights
The global Inhalers and Nebulizers market was valued at US$ 14010 million in 2022 and is anticipated to reach US$ 18410 million by 2029, witnessing a CAGR of 3.9% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
Global key manufacturers of Inhalers and Nebulizers include GSK, AstraZeneca, Chiesi, Boehringer Ingelheim, Teva, etc. Global top five manufacturers hold a share about 75%. North America is the largest market of Inhalers and Nebulizers, holds a share over 35%. In terms of product, the Inhalers holds a share of over 90%. And in terms of application, the largest application field is Asthma, with a share of over 45%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Inhalers and Nebulizers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inhalers and Nebulizers.
The Inhalers and Nebulizers market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Inhalers and Nebulizers market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inhalers and Nebulizers manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
GSK
AstraZeneca
Chiesi
Boehringer Ingelheim
Novartis
Teva
Organon
PARI GmbH
Omron
Philips
Drive DeVilbiss Healthcare
Yuwell
Leyi
Folee
Beurer
Segment by Type
Inhalers
Nebulizer
Segment by Application
Asthma
COPD
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Inhalers and Nebulizers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Inhalers and Nebulizers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Inhalers and Nebulizers market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inhalers and Nebulizers market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Inhalers and Nebulizers and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Inhalers and Nebulizers industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inhalers and Nebulizers.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Inhalers and Nebulizers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Inhalers and Nebulizers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Analysis of sales channel, distributors and customers
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: sales and revenue forecast, global and regional, by Type and by Application. It provides a quantitative analysis of the market size and development potential of each market segment in the next six years.
Chapter 11: The main points and conclusions of the report.

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Inhalers and Nebulizers Market Overview
1.1 Product Overview and Scope of Inhalers and Nebulizers
1.2 Inhalers and Nebulizers Segment by Type
1.2.1 Global Inhalers and Nebulizers Market Value Comparison by Type (2023-2029)
1.2.2 Inhalers
1.2.3 Nebulizer
1.3 Inhalers and Nebulizers Segment by Application
1.3.1 Global Inhalers and Nebulizers Market Value by Application: (2023-2029)
1.3.2 Asthma
1.3.3 COPD
1.3.4 Others
1.4 Global Inhalers and Nebulizers Market Size Estimates and Forecasts
1.4.1 Global Inhalers and Nebulizers Revenue 2018-2029
1.4.2 Global Inhalers and Nebulizers Sales 2018-2029
1.4.3 Global Inhalers and Nebulizers Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Inhalers and Nebulizers Market Competition by Manufacturers
2.1 Global Inhalers and Nebulizers Sales Market Share by Manufacturers (2018-2023)
2.2 Global Inhalers and Nebulizers Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Inhalers and Nebulizers Average Price by Manufacturers (2018-2023)
2.4 Global Inhalers and Nebulizers Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Inhalers and Nebulizers, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Inhalers and Nebulizers, Product Type & Application
2.7 Inhalers and Nebulizers Market Competitive Situation and Trends
2.7.1 Inhalers and Nebulizers Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Inhalers and Nebulizers Players Market Share by Revenue
2.7.3 Global Inhalers and Nebulizers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Inhalers and Nebulizers Retrospective Market Scenario by Region
3.1 Global Inhalers and Nebulizers Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Inhalers and Nebulizers Global Inhalers and Nebulizers Sales by Region: 2018-2029
3.2.1 Global Inhalers and Nebulizers Sales by Region: 2018-2023
3.2.2 Global Inhalers and Nebulizers Sales by Region: 2024-2029
3.3 Global Inhalers and Nebulizers Global Inhalers and Nebulizers Revenue by Region: 2018-2029
3.3.1 Global Inhalers and Nebulizers Revenue by Region: 2018-2023
3.3.2 Global Inhalers and Nebulizers Revenue by Region: 2024-2029
3.4 North America Inhalers and Nebulizers Market Facts & Figures by Country
3.4.1 North America Inhalers and Nebulizers Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Inhalers and Nebulizers Sales by Country (2018-2029)
3.4.3 North America Inhalers and Nebulizers Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Inhalers and Nebulizers Market Facts & Figures by Country
3.5.1 Europe Inhalers and Nebulizers Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Inhalers and Nebulizers Sales by Country (2018-2029)
3.5.3 Europe Inhalers and Nebulizers Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Inhalers and Nebulizers Market Facts & Figures by Country
3.6.1 Asia Pacific Inhalers and Nebulizers Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Inhalers and Nebulizers Sales by Country (2018-2029)
3.6.3 Asia Pacific Inhalers and Nebulizers Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Inhalers and Nebulizers Market Facts & Figures by Country
3.7.1 Latin America Inhalers and Nebulizers Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Inhalers and Nebulizers Sales by Country (2018-2029)
3.7.3 Latin America Inhalers and Nebulizers Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Inhalers and Nebulizers Market Facts & Figures by Country
3.8.1 Middle East and Africa Inhalers and Nebulizers Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Inhalers and Nebulizers Sales by Country (2018-2029)
3.8.3 Middle East and Africa Inhalers and Nebulizers Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Inhalers and Nebulizers Sales by Type (2018-2029)
4.1.1 Global Inhalers and Nebulizers Sales by Type (2018-2023)
4.1.2 Global Inhalers and Nebulizers Sales by Type (2024-2029)
4.1.3 Global Inhalers and Nebulizers Sales Market Share by Type (2018-2029)
4.2 Global Inhalers and Nebulizers Revenue by Type (2018-2029)
4.2.1 Global Inhalers and Nebulizers Revenue by Type (2018-2023)
4.2.2 Global Inhalers and Nebulizers Revenue by Type (2024-2029)
4.2.3 Global Inhalers and Nebulizers Revenue Market Share by Type (2018-2029)
4.3 Global Inhalers and Nebulizers Price by Type (2018-2029)
5 Segment by Application
5.1 Global Inhalers and Nebulizers Sales by Application (2018-2029)
5.1.1 Global Inhalers and Nebulizers Sales by Application (2018-2023)
5.1.2 Global Inhalers and Nebulizers Sales by Application (2024-2029)
5.1.3 Global Inhalers and Nebulizers Sales Market Share by Application (2018-2029)
5.2 Global Inhalers and Nebulizers Revenue by Application (2018-2029)
5.2.1 Global Inhalers and Nebulizers Revenue by Application (2018-2023)
5.2.2 Global Inhalers and Nebulizers Revenue by Application (2024-2029)
5.2.3 Global Inhalers and Nebulizers Revenue Market Share by Application (2018-2029)
5.3 Global Inhalers and Nebulizers Price by Application (2018-2029)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Inhalers and Nebulizers Sales, Revenue and Gross Margin (2018-2023)
6.1.4 GSK Inhalers and Nebulizers Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Corporation Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Inhalers and Nebulizers Sales, Revenue and Gross Margin (2018-2023)
6.2.4 AstraZeneca Inhalers and Nebulizers Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Chiesi
6.3.1 Chiesi Corporation Information
6.3.2 Chiesi Description and Business Overview
6.3.3 Chiesi Inhalers and Nebulizers Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Chiesi Inhalers and Nebulizers Product Portfolio
6.3.5 Chiesi Recent Developments/Updates
6.4 Boehringer Ingelheim
6.4.1 Boehringer Ingelheim Corporation Information
6.4.2 Boehringer Ingelheim Description and Business Overview
6.4.3 Boehringer Ingelheim Inhalers and Nebulizers Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Boehringer Ingelheim Inhalers and Nebulizers Product Portfolio
6.4.5 Boehringer Ingelheim Recent Developments/Updates
6.5 Novartis
6.5.1 Novartis Corporation Information
6.5.2 Novartis Description and Business Overview
6.5.3 Novartis Inhalers and Nebulizers Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Novartis Inhalers and Nebulizers Product Portfolio
6.5.5 Novartis Recent Developments/Updates
6.6 Teva
6.6.1 Teva Corporation Information
6.6.2 Teva Description and Business Overview
6.6.3 Teva Inhalers and Nebulizers Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Teva Inhalers and Nebulizers Product Portfolio
6.6.5 Teva Recent Developments/Updates
6.7 Organon
6.6.1 Organon Corporation Information
6.6.2 Organon Description and Business Overview
6.6.3 Organon Inhalers and Nebulizers Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Organon Inhalers and Nebulizers Product Portfolio
6.7.5 Organon Recent Developments/Updates
6.8 PARI GmbH
6.8.1 PARI GmbH Corporation Information
6.8.2 PARI GmbH Description and Business Overview
6.8.3 PARI GmbH Inhalers and Nebulizers Sales, Revenue and Gross Margin (2018-2023)
6.8.4 PARI GmbH Inhalers and Nebulizers Product Portfolio
6.8.5 PARI GmbH Recent Developments/Updates
6.9 Omron
6.9.1 Omron Corporation Information
6.9.2 Omron Description and Business Overview
6.9.3 Omron Inhalers and Nebulizers Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Omron Inhalers and Nebulizers Product Portfolio
6.9.5 Omron Recent Developments/Updates
6.10 Philips
6.10.1 Philips Corporation Information
6.10.2 Philips Description and Business Overview
6.10.3 Philips Inhalers and Nebulizers Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Philips Inhalers and Nebulizers Product Portfolio
6.10.5 Philips Recent Developments/Updates
6.11 Drive DeVilbiss Healthcare
6.11.1 Drive DeVilbiss Healthcare Corporation Information
6.11.2 Drive DeVilbiss Healthcare Inhalers and Nebulizers Description and Business Overview
6.11.3 Drive DeVilbiss Healthcare Inhalers and Nebulizers Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Drive DeVilbiss Healthcare Inhalers and Nebulizers Product Portfolio
6.11.5 Drive DeVilbiss Healthcare Recent Developments/Updates
6.12 Yuwell
6.12.1 Yuwell Corporation Information
6.12.2 Yuwell Inhalers and Nebulizers Description and Business Overview
6.12.3 Yuwell Inhalers and Nebulizers Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Yuwell Inhalers and Nebulizers Product Portfolio
6.12.5 Yuwell Recent Developments/Updates
6.13 Leyi
6.13.1 Leyi Corporation Information
6.13.2 Leyi Inhalers and Nebulizers Description and Business Overview
6.13.3 Leyi Inhalers and Nebulizers Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Leyi Inhalers and Nebulizers Product Portfolio
6.13.5 Leyi Recent Developments/Updates
6.14 Folee
6.14.1 Folee Corporation Information
6.14.2 Folee Inhalers and Nebulizers Description and Business Overview
6.14.3 Folee Inhalers and Nebulizers Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Folee Inhalers and Nebulizers Product Portfolio
6.14.5 Folee Recent Developments/Updates
6.15 Beurer
6.15.1 Beurer Corporation Information
6.15.2 Beurer Inhalers and Nebulizers Description and Business Overview
6.15.3 Beurer Inhalers and Nebulizers Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Beurer Inhalers and Nebulizers Product Portfolio
6.15.5 Beurer Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Inhalers and Nebulizers Industry Chain Analysis
7.2 Inhalers and Nebulizers Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Inhalers and Nebulizers Production Mode & Process
7.4 Inhalers and Nebulizers Sales and Marketing
7.4.1 Inhalers and Nebulizers Sales Channels
7.4.2 Inhalers and Nebulizers Distributors
7.5 Inhalers and Nebulizers Customers
8 Inhalers and Nebulizers Market Dynamics
8.1 Inhalers and Nebulizers Industry Trends
8.2 Inhalers and Nebulizers Market Drivers
8.3 Inhalers and Nebulizers Market Challenges
8.4 Inhalers and Nebulizers Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer


※参考情報

吸入器とネブライザーは、呼吸器系の疾患の治療に不可欠な医療機器です。これらは、患者が薬物を直接肺に届けるための装置であり、効果的な治療を提供します。ここでは、吸入器とネブライザーの基本的な概念、特徴、種類、用途、関連技術について詳しく解説いたします。

まず、吸入器とは、主に粉末またはエアロゾル状の薬剤を吸入するための装置であり、喘息や慢性閉塞性肺疾患（COPD）などの病状の管理に使用されます。吸入器の特徴は、薬剤を直接肺に届けることで、全身への影響を最小限に抑え、局所的に効果を発揮する点にあります。吸入器には、定量噴霧器（MDI）やディスカッシング吸入器（DPI）などの異なるタイプがあります。

定量噴霧器は、薬剤を一定量噴霧する機能を持つ装置であり、具体的には小型の缶に圧縮された薬剤を含んでいます。使用する際には、患者がバルブを押しながら吸入し、一定量の薬剤を肺に届けます。一方、ディスカッシング吸入器は、粉末状の薬剤を使用し、吸引によって薬剤を肺に送ります。これらは通常、持ち運びが簡単で、手軽に使用できることから、多くの患者にとって便利な選択肢とされています。

次に、ネブライザーですが、これは液体状の薬剤を微細な霧として噴霧するデバイスであり、主に重症患者や小児の治療に使用されることが一般的です。ネブライザーは、電源を使用する電動式や、圧縮空気を使用して薬剤を霧化する空気圧式があり、それぞれ特徴があります。電動式は、通常、家庭用や病院での使用を目的とし、例えば、喘息の発作時や慢性呼吸器疾患の治療に非常に効果的です。

ネブライザーの利点は、薬剤を微細な霧として供給するため、肺の奥まで届きやすいことです。これにより、吸入器が難しい赤ちゃんや高齢者など、吸入力が弱い患者でも使用が可能です。また、使用の際に特別な吸入技術が必要ないため、患者にとっても扱いやすい医療機器となっています。

これらのデバイスは、さまざまな健康状態に応じて異なる種類の薬剤を使用することができます。例えば、気管支拡張薬、抗炎症薬、吸入ステロイド、抗生物質などがあり、これらを適切に組み合わせることで治療の効果を最大化することが可能です。また、特定の病状に応じたカスタマイズ治療を行うことができるため、医師は患者の状態に基づいて適切な治療計画を立てることが重要です。

関連技術としては、吸入器やネブライザーの使用を支援するための電子機器やアプリケーションが挙げられます。吸入器にBluetooth機能を搭載したものや、使用履歴を記録するスマートデバイスが進化しています。これにより、患者は自分の健康状態を把握しやすくなり、医師とのコミュニケーションも向上します。また、デジタルヘルス技術の発展に伴い、リモートモニタリングやオンライン診療も普及しています。

さらに、近年では、吸入技術に関する研究が進められており、新たな薬剤送達システムの開発が行われています。これら新技術の導入により、より効果的で安全な治療が期待されるとともに、患者の生活の質を向上させることが目指されています。

最後に、吸入器とネブライザーの使用には、正しい使用法やメンテナンスが極めて重要です。誤った使用は、薬剤の効果を低下させる可能性があるため、医療従事者からの指導を受けることが求められます。また、定期的なチェックやメンテナンスを行うことで、長期間にわたってデバイスを使用することができます。

このように、吸入器とネブライザーは、呼吸器系の疾患に対して非常に重要な役割を担っており、患者の健康管理に寄与しています。今後も技術の進化により、より良い治療法が確立されることが期待されています。


★調査レポート[吸入器＆ネブライザーのグローバル市場2023年：吸入器、ネブライザー] (コード：QYR23MA7988)販売に関する免責事項を必ずご確認ください。
★調査レポート[吸入器＆ネブライザーのグローバル市場2023年：吸入器、ネブライザー]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の肺薬物送達装置市場2023-2031：製品種類別（ドライパウダー吸入器、定量吸入器、ネブライザー）、用途別（喘息、COPD、嚢胞性線維症）
  • 世界の喘息治療薬市場2023-2030：薬剤クラス別（抗炎症薬、併用療法）、製品別（吸入器、ネブライザー）、投与経路別、地域別
  • スマート吸入器技術のグローバル市場2023-2027：吸入器、ネブライザー
  • ブデソニド吸入器のグローバル市場（2023-2030）：吸入剤、ネブライザー

    • ◆H&Iグローバルリサーチのお客様（例）◆